Keros Therapeutics, Inc. (KROS) Stock price, Description, News & Info
#Thinksabio latest news Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the...
#Thinksabio latest news Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the...
#Thinksabio latest news BioAtla Announces Regulatory Update on Clinical Development Plan for Ozuriftamab Vedotin in...
#Thinksabio latest news Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters with GaN, Built...
#Thinksabio latest news Alignment Healthcare Names Matt Eyles Executive Vice President of Government & Business...
#Thinksabio latest news TG Announces Phase 3 Trial for Subcutaneous BRIUMVI Commenced EnrollmentPhase 3 trial...
#Thinksabio latest news Cybin Completes Enrollment in Phase 2 Study Evaluating CYB004 for the Treatment...
#Thinksabio latest news Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase...
PNC Announces Agreement to Acquire FirstBank, Significantly Growing its Presence in Colorado and Arizona
#ThinkSabio Trending Stock Gainers: #OCTO #KRKR #RAPP #XAIR #FORD #HOUR #PL Penny Gainers: #SKYQ #ILLR...
#ThinkSabio Trending Stock Gainers: #HDB #MTEX #AMBO #IMCC #VGAS #CARU #SUGP Penny Gainers: #GNPX #SKYQ...